Standard
Impact of SHP2 tyrosine phosphorylation on the development of acquired resistance to allosteric SHP2 inhibitors. / Franciosa, Giulia; Olsen, Jesper V.
In:
OncoTarget, Vol. 14, 2023, p. 281-283.
Research output: Contribution to journal › Editorial › Research › peer-review
Harvard
Franciosa, G & Olsen, JV 2023, '
Impact of SHP2 tyrosine phosphorylation on the development of acquired resistance to allosteric SHP2 inhibitors',
OncoTarget, vol. 14, pp. 281-283.
https://doi.org/10.18632/oncotarget.28392
APA
Franciosa, G., & Olsen, J. V. (2023).
Impact of SHP2 tyrosine phosphorylation on the development of acquired resistance to allosteric SHP2 inhibitors.
OncoTarget,
14, 281-283.
https://doi.org/10.18632/oncotarget.28392
Vancouver
Franciosa G, Olsen JV.
Impact of SHP2 tyrosine phosphorylation on the development of acquired resistance to allosteric SHP2 inhibitors.
OncoTarget. 2023;14:281-283.
https://doi.org/10.18632/oncotarget.28392
Author
Franciosa, Giulia ; Olsen, Jesper V. / Impact of SHP2 tyrosine phosphorylation on the development of acquired resistance to allosteric SHP2 inhibitors. In: OncoTarget. 2023 ; Vol. 14. pp. 281-283.
Bibtex
@article{ca2d5b9b3d9446d29081c5b372fdd0c6,
title = "Impact of SHP2 tyrosine phosphorylation on the development of acquired resistance to allosteric SHP2 inhibitors",
keywords = "Humans, Phosphorylation, Cell Line, Tumor, Protein Kinase Inhibitors/pharmacology, Tyrosine, Protein Tyrosine Phosphatase, Non-Receptor Type 11/genetics, Enzyme Inhibitors/pharmacology",
author = "Giulia Franciosa and Olsen, {Jesper V}",
year = "2023",
doi = "10.18632/oncotarget.28392",
language = "English",
volume = "14",
pages = "281--283",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals LLC",
}
RIS
TY - JOUR
T1 - Impact of SHP2 tyrosine phosphorylation on the development of acquired resistance to allosteric SHP2 inhibitors
AU - Franciosa, Giulia
AU - Olsen, Jesper V
PY - 2023
Y1 - 2023
KW - Humans
KW - Phosphorylation
KW - Cell Line, Tumor
KW - Protein Kinase Inhibitors/pharmacology
KW - Tyrosine
KW - Protein Tyrosine Phosphatase, Non-Receptor Type 11/genetics
KW - Enzyme Inhibitors/pharmacology
U2 - 10.18632/oncotarget.28392
DO - 10.18632/oncotarget.28392
M3 - Editorial
C2 - 36999992
VL - 14
SP - 281
EP - 283
JO - Oncotarget
JF - Oncotarget
SN - 1949-2553
ER -